Ovid Therapeutics (OVID) Amortizatization of Intangibles (2022 - 2026)

Ovid Therapeutics (OVID) has reported Amortizatization of Intangibles for 5 consecutive years, with $318000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Amortizatization of Intangibles rose 8.16% year-over-year to $318000.0; the trailing twelve-month figure through Jun 2026 stood at $1.2 million (up 8.24% YoY), and the FY2025 full-year result was $1.2 million, up 8.2% from the prior year.
• Amortizatization of Intangibles climbed to $318000.0 in Q2 2026 per OVID's latest filing, from $312000.0 in the prior quarter.
• Across five years, Amortizatization of Intangibles topped out at $354185.0 in Q2 2022 and bottomed at $253000.0 in Q1 2023.
• Historically, Amortizatization of Intangibles has averaged $283005.9 across 5 years, with a median of $277000.0 in 2024.
• The sharpest annual moves came in 2023 and 2026: Amortizatization of Intangibles slipped 27.16% in 2023, then increased 8.33% in 2026.
• Over 5 years, Amortizatization of Intangibles stood at $254970.0 in 2022, then increased by 2.36% to $261000.0 in 2023, then rose by 8.05% to $282000.0 in 2024, then rose by 8.16% to $305000.0 in 2025, then increased by 4.26% to $318000.0 in 2026.
• According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $318000.0, $312000.0, and $305000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.